Global Neuropathic Pain market size is expected to reach $6.78 billion by 2030 at 35.8%, segmented as by medications, anticonvulsants, antidepressants, opioids, topical treatments, non-steroidal anti-inflammatory drugs (nsaids)
Read MoreGlobal Neurotechnology market size is expected to reach $33.64 billion by 2030 at 14.1%, neurological conditions’ surge catalyst for neurotechnology market expansion
Read MoreGlobal Neuroscience market size is expected to reach $54.01 billion by 2030 at 7.6%, surging geriatric demographics fueling growth in the neuroscience market
Read MoreGlobal Neuroprosthetics market size is expected to reach $23.1 billion by 2030 at 14.6%, neuroprosthetics market soars as global neurological disorder and nerve injury cases surge
Read MoreGlobal Neuroplasticity market size is expected to reach $18.48 by 2030 at 22.9%, rising burden of neurological disorders fueling the growth of the market due to increasing demand for advanced brain therapies
Read MoreGlobal Neurotrophic Keratitis Treatment market size is expected to reach $8.48 billion by 2030 at 8.1%, segmented as by topical antibiotics, broad-spectrum antibiotics, narrow-spectrum antibiotics
Read MoreGlobal Neuromyelitis Optica Spectrum Disorder market size is expected to reach $3.76 Billion by 2030 at 8.1%, rising multiple sclerosis cases fueling the growth of the market due to improved diagnostics and increased awareness
Read MoreThe global Neurology Clinical Trials market size is expected to reach over $8.05 billion by 2030 at 6.7% CAGR, driven by the increasing prevalence of neurological disorders.
Read MoreThe neurological disorder diagnostics market is set to reach $17.75 billion by 2030, growing at 7% CAGR, driven by AI-based neuroimaging, biomarkers, and precision neurology tools.
Read MoreGlobal Neurological Biomarkers market size is expected to reach $22.82 billion by 2030 at 14%, rising prevalence of neurological diseases fuels momentum in neurological biomarker market
Read More
